Culprit Vessel Percutaneous Coronary Intervention Versus Multivessel and Staged Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction Patients With Multivessel Disease

被引:255
|
作者
Hannan, Edward L. [1 ]
Samadashvili, Zaza
Walford, Gary [2 ]
Holmes, David R., Jr. [3 ]
Jacobs, Alice K. [4 ]
Stamato, Nicholas J. [6 ]
Venditti, Ferdinand J. [5 ]
Sharma, Samin [7 ]
King, Spencer B., III [8 ]
机构
[1] SUNY Albany, Sch Publ Hlth, Rensselaer, NY 12144 USA
[2] St Josephs Hosp, Syracuse, NY USA
[3] Mayo Clin, Rochester, MN USA
[4] Boston Univ, Med Ctr, Boston, MA USA
[5] Albany Med Ctr, Albany, NY USA
[6] United Hlth Serv, Binghamton, NY USA
[7] Mt Sinai Med Ctr, New York, NY 10029 USA
[8] St Josephs Hlth Syst, Atlanta, GA USA
关键词
DRUG-ELUTING STENTS; BARE-METAL STENTS; REVASCULARIZATION; METAANALYSIS; OUTCOMES; SAFETY; SINGLE;
D O I
10.1016/j.jcin.2009.10.017
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives The purpose of this study was to examine the differences in in-hospital and longer-term mortality for ST-segment elevation myocardial infarction (STEMI) patients with multivessel disease as a function of whether they underwent single-vessel (culprit vessel) percutaneous coronary interventions (PCIs) or multivessel PCI. Background The optimal treatment of patients with STEMI and multivessel disease is of continuing interest in the era of drug-eluting stents. Methods STEMI patients with multivessel disease undergoing PCIs in New York between January 1, 2003, and June 30, 2006, were subdivided into those who underwent culprit vessel PCI and those who underwent multivessel PCI during the index procedure, during the index admission, or staged within 60 days of the index admission. Patients were propensity-matched and mortality rates were calculated at 12, 24, and 42 months. Results A total of 3,521 patients (87.5%) underwent culprit vessel PCI during the index procedure. A total of 259 of them underwent staged PCI during the index admission and 538 patients underwent staged PCI within 60 days of the index procedure. For patients without hemodynamic compromise, culprit vessel PCI during the index procedure was associated with lower in-hospital mortality than multivessel PCI during the index procedure (0.9% vs. 2.4%, p = 0.04). Patients undergoing staged multivessel PCI within 60 days after the index procedure had a significantly lower 12-month mortality rate than patients undergoing culprit vessel PCI only (1.3% vs. 3.3%, p = 0.04). Conclusions Our findings support the American College of Cardiology/American Heart Association (ACC/AHA) recommendation that culprit vessel PCI be used for STEMI patients with multivessel disease at the time of the index PCI when patients are not hemodynamically compromised. However, staged PCI within 60 days after the index procedure, including during the index admission, is associated with risk-adjusted mortality rates that are comparable with the rate for culprit vessel PCI alone. (J Am Coll Cardiol Intv 2010;3:22-31) (C) 2010 by the American College of Cardiology Foundation
引用
收藏
页码:22 / 31
页数:10
相关论文
共 50 条
  • [41] OUTCOMES FOLLOWING MULTIVESSEL OR CULPRIT VESSEL REVASCULARIZATIONS AT THE TIME OF PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN ST -ELEVATION MYOCARDIAL INFARCTION PATIENTS WITH CARDIOGENIC SHOCK AND MULTIVESSEL DISEASE
    Park, Jin Sup
    Cha, Kwang Soo
    Lee, Hye Won
    Kim, Bo Won
    Choi, Jong Hyeon
    Oh, Jun-Hyok
    Choi, Jung Hyun
    Choi, Jeong Cheon
    Lee, Han Cheol
    Hong, Taek Jong
    Jeong, Myung Ho
    Ahn, Youngkeun
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A71 - A71
  • [42] Multivessel percutaneous coronary intervention in patients with multivessel disease and acute myocardial infarction
    Corpus, RA
    House, JA
    Marso, SP
    Grantham, A
    Huber, KC
    Laster, SB
    Johnson, WL
    Daniels, WC
    Barth, CW
    Giorgi, LV
    Rutherford, BD
    AMERICAN HEART JOURNAL, 2004, 148 (03) : 493 - 500
  • [43] Three-year clinical outcomes of staged, ad hoc and culprit-only percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease
    Kim, Min Chul
    Jeong, Myung Ho
    Park, Keun Ho
    Sim, Doo Sun
    Yoon, Nam Sik
    Yoon, Hyun Joo
    Kim, Kye Hun
    Hong, Young Joon
    Park, Hyung Wook
    Kim, Ju Han
    Ahn, Youngkeun
    Cho, Jeong Gwan
    Park, Jong Chun
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 176 (02) : 505 - 507
  • [44] MULTIVESSEL VERSUS CULPRIT-ONLY PRIMARY PERCUTANEOUS CORONARY INTERVENTION IN PATIENTS WITH MULTIVESSEL DISEASE AND ST-ELEVATION MYOCARDIAL INFARCTION COMPLICATED WITH CARDIOGENIC SHOCK
    Claessen, Bimmer
    Vis, Marije M.
    Koch, Karel T.
    Baan, Jan, Jr.
    Meuwissen, Martijn
    de Winter, Rob J.
    Tijssen, Jan G.
    Piek, Jan J.
    Henriques, Jose P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [45] Effect of Multivessel Revascularization during Primary Percutaneous Coronary Intervention on Outcomes of Patients with ST-Segment Elevation Myocardial Infarction
    Estevez-Loureiro, Rodrigo
    Rodriguez-Vilela, Alejandro
    Salgado-Fernandez, Jorge
    Barge-Caballero, Eduardo
    Calvino-Santos, Ramon
    Vazquez-Rodriguez, Jose
    Aldama-Lopez, Guillermo
    Pinon-Esteban, Pablo
    Vazquez-Gonzalez, Nicolas
    Castro-Beiras, Alfonso
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (9A): : 1B - 2B
  • [46] Impact of Multivessel Percutaneous Coronary Intervention vs. Culprit Vessel Percutaneous Coronary Intervention in Patients with Acute Coronary Syndromes and Multivessel Coronary Artery Disease
    Yasuda, Kentaro
    Ogita, Manabu
    Tsuboi, Shuta
    Nishio, Ryota
    Takeuchi, Mitsuhiro
    Sonoda, Taketo
    Wada, Hideki
    Suwa, Satoru
    Miyauchi, Katsumi
    Daida, Hiroyuki
    Minamino, Tohru
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2023, 53 : 38 - 44
  • [47] Single or Multivessel Percutaneous Coronary Intervention in ST-Elevation Myocardial Infarction Patients
    Varani, Elisabetta
    Balducelli, Marco
    Aquilina, Matteo
    Vecchi, Giuseppe
    Hussien, Mohamed Naseem
    Frassineti, Valeria
    Maresta, Aleardo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2008, 72 (07) : 927 - 933
  • [48] Management of multivessel coronary disease detected at the time of primary percutaneous coronary intervention in st-segment elevation myocardial infarction: preliminary analysis
    Pedro Magalhaes, P.
    Leao, S.
    Cordeiro, F.
    Ribeiro, H.
    Seca, L.
    Carvalho, S.
    Sousa, P.
    Moreira, J. I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 : 366 - 366
  • [49] A comparison of multivessel and culprit vessel percutaneous coronary intervention in non-ST-segment elevation acute coronary syndrome patients with multivessel disease: a meta-analysis
    Qiao, Yan
    Li, Weiju
    Mohamed, Salim
    Nie, Shaoping
    Du, Xin
    Zhang, Yin
    Jia, Changqi
    Wang, Xiao
    Liu, Xiaohui
    Ma, Changsheng
    EUROINTERVENTION, 2015, 11 (05) : 525 - 532
  • [50] Culprit vessel-only vs. multivessel percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction and multivessel disease: results from an 8-year prospective registry
    Galvao Braga, C.
    Cid-Alvarez, B.
    Trillo-Nouche, R.
    Redondo Dieguez, A.
    Alvarez-Alvarez, B.
    Lopez Otero, D.
    Gestal-Romani, S.
    Ferreiro Gonzalez, R.
    Gonzalez-Juanatey, J. R.
    EUROPEAN HEART JOURNAL, 2016, 37 : 821 - 821